At a glance
ClinicalIndex Comparison RecordN/ACompleted· 153 enrolled
Drug / intervention
Verofilcon A toric soft contact lenses +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses
In Brief
A clinical study evaluating Verofilcon A toric soft contact lenses and Stenfilcon A toric soft contact lenses for Astigmatism and 2 related conditions. Completed, enrolled 153 participants across 11 sites.
Detailed Summary
The primary purpose of this study is to demonstrate noninferiority in the visual acuity at distance when wearing PRECISION1™ for Astigmatism (P1fA) soft contact lenses compared to another commercially available, soft toric contact lens, MyDay® toric (MDT).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAstigmatism, Ametropia, Myopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedAug 2022
Enrollment StartSep 2022
Primary CompletionOct 2022
TodayJul 2026
First PostedAug 1, 2022
Enrollment StartSep 13, 2022
Primary CompletionOct 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.9 years ago
Interventions
Verofilcon A toric soft contact lensesdevice
Soft contact lenses for optical correction of ametropia and astigmatism
Stenfilcon A toric soft contact lensesdevice
Soft contact lenses for optical correction of ametropia and astigmatism